comparemela.com
Home
Live Updates
MEI Pharma, Inc. (MEIP) Reports Q2 Loss, Misses Revenue Estimates : comparemela.com
MEI Pharma, Inc. (MEIP) Reports Q2 Loss, Misses Revenue Estimates
MEI Pharma, Inc. (MEIP) delivered earnings and revenue surprises of -13.70% and 100%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Related Keywords
,
Zacks Investment Research ,
Pharma Inc ,
Mei Pharma Inc ,
Zacks Consensus Estimate ,
Zacks Medical ,
Zacks Rank ,
Strong Buy ,
Zacks Industry Rank ,
Zacks Investment ,
Mei Pharma ,
Nc ,
Stimate Revisions ,
Quarterly Loss ,
Consensus Earnings ,
Consensus Eps Estimate ,
comparemela.com © 2020. All Rights Reserved.